POINT Biopharma Global - Delisted Stock
POINT Biopharma Global is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day POINT Biopharma was actively traded.
Valuation
Financial Report 20th of May 2024
POINT Biopharma Global Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. POINT Biopharma market risk premium is the additional return an investor will receive from holding POINT Biopharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in POINT Biopharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although POINT Biopharma's alpha and beta are two of the key measurements used to evaluate POINT Biopharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.77 | |||
| Semi Deviation | 1.33 | |||
| Standard Deviation | 10.59 | |||
| Variance | 112.15 |
View POINT Biopharma Related Equities
| Risk & Return | Correlation |
POINT Biopharma Corporate Management
Elected by the shareholders, the POINT Biopharma's board of directors comprises two types of representatives: POINT Biopharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of POINT. The board's role is to monitor POINT Biopharma's management team and ensure that shareholders' interests are well served. POINT Biopharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, POINT Biopharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MPH MPH | Ex Devel | Profile | |
| FRCSC MD | Chief Director | Profile | |
| Ari Shomair | VP Staff | Profile | |
| Joe McCann | CEO Director | Profile | |
| Donna BA | VP HR | Profile | |
| RPh Herle | Ex Affairs | Profile | |
| BBA FCA | Chief Officer | Profile |
Still Interested in POINT Biopharma Global?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in POINT Stock
If you are still planning to invest in POINT Biopharma Global check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the POINT Biopharma's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| CEOs Directory Screen CEOs from public companies around the world |